Volume 13, Number 6—June 2007
Research
Minority-Variant pfcrt K76T Mutations and Chloroquine Resistance, Malawi
Jonathan J. Juliano*, Jesse J. Kwiek*, Kathryn Cappell*, Victor Mwapasa†, and Steven R Meshnick*
Table 1
Characteristics of patient samples*
| Characteristic | Value (range) |
|---|---|
| Age (y) | |
| Total | 21.9 (15–35) |
| MHP patients | 23.7 (17–31) |
| MM patients | 21.2 (15–35) |
| Parasite density (no. parasites/200 leukocytes) | |
| Total | 243.6 (4–2,202) |
| MHP patients | 599.7 (4–2,202) |
| MM patients | 83.3 (5–750) |
| Gravidity | |
| Total | 2.26 (1–9) |
| MHP patients | 2.37 (1–3) |
| MM patients | 2.21 (1–9) |
| Anemia (hemoglobin <11 g/dL) | |
| Total | 64/87 (73.6%) |
| MHP patients | 21/27 (77.8%) |
| MM patients | 43/60 (71.7%) |
| HIV status | |
| Total† | 38/58 (65.5%) |
| MHP patients | 27/27 (100%) |
| MM patients | 11/31 (35.5%) |
| Clinical symptoms‡ | |
| Fever | 14/27 (51.8%) |
| Headache | 18/27 (66.7%) |
| General body pain | 13/27 (48.1%) |
| Preventive measures‡ | |
| Bed net use§ | 6/19 (31.6%) |
*MHP, Malaria and HIV in Pregnancy; MM, Mpemba and Madziabango.
†29 patients declined testing.
‡Data only available for MHP patients.
§No data available for 8 patients.
